GSK Velu

Premium

General

04 December, 2023

Stakeboat's Kandasamy on new fund strategy, core investment areas and exit timing

Homegrown mid-market private equity investor Stakeboat Capital has been on an upward trajectory after ticking multiple right boxes in 2023. Apart ......

Premium

Finance

18 September, 2023

Stakeboat's second PE fund oversubscribed; AUM crosses $150 mn

Mid-market private equity firm Stakeboat Capital has marked the final close of its second fund with oversubscription, pushing its total ......

Premium

Healthcare

15 June, 2023

Exclusive: GSK Velu's eyecare chain Maxivision set to close new PE round

Maxivision Eye Hospital is in an advanced stage of discussions with several private equity investors to raise a funding round, ......

Premium

Healthcare

24 April, 2023

GSK Velu's Neuberg takes M&A route after missing revenue target

Neuberg Diagnostics Pvt. Ltd, the pathology chain set up by healthcare entrepreneur GSK Velu more than five years ago, has ......

Premium

Healthcare

18 February, 2021

Stakeboat, now raising second fund, has a couple more arrows left in first-fund quiver

Mid-market private equity firm Stakeboat Capital, which hit the road last month to raise its second fund of Rs 1,000 ......

Premium

Finance

24 November, 2020

GSK Velu-backed Stakeboat Capital floats new fund

Stakeboat Capital, a mid-market private equity firm backed and launched by serial healthcare entrepreneur GSK Velu, has launched its new ......

Premium

Healthcare

04 September, 2020

LGT Lightstone-backed Kauvery Hospital to make Bengaluru acquisition

Tamil Nadu-based hospital chain Kauvery Hospital, which received investment from impact investor LGT Lightstone Aspada last year, said it will ......

Premium

Healthcare

16 March, 2020

Coronavirus: Pathology chains wait on the sidelines, device makers gear up

The number of confirmed coronavirus cases (COVID-19), which was declared a pandemic by the World Health Organization (WHO) last week, ......

Premium

Healthcare

13 February, 2020

Explained: How treating medical devices as ‘drugs' will affect companies, investors

From April, all medical devices sold in India will be treated as ‘drugs’. On Tuesday, the central government issued a ......

Premium

Healthcare

21 November, 2019

Trivitron tweaks IPO plan as it weighs exit options for PE investors

Medical devices maker Trivitron Healthcare Pvt. Ltd is considering the possibility of deferring its initial public offering plan and looking ......